Tune in to this webinar to learn how reporter-gene assays, in combination with complement system assays, can be used to determine drug mechanisms of action and the expected immune response.
In this webinar, Therese Segerstein and Ali Qamar, explain how functional assays can be used in safe and compliant biopharmaceutical development. They focus on functional platforms for complement assessment and cell-based solutions for measurement and quantification of drug potency, detection of neutralizing antibodies (NAbs), and assessment of immunogenicity.
Tune in to this webinar to learn how reporter-gene assays, in combination with complement system assays, can be used to determine drug mechanisms of action and the expected immune response.
In this webinar, Therese Segerstein and Ali Qamar, explain how functional assays can be used in safe and compliant biopharmaceutical development. They focus on functional platforms for complement assessment and cell-based solutions for measurement and quantification of drug potency, detection of neutralizing antibodies (NAbs), and assessment of immunogenicity.
Key learning objectives
Who should attend?
Time: 57 min
Ali Qamar
Product Manager
View LinkedIn Profile
In biopharmaceutical development, functional assays are key to showing that a drug target fits the desired functionality and quality profile before moving on to the next stage of development. Often, more than one assay is required since biopharmaceuticals may have more than one mechanism of action (MoA).
Reporter-gene assays are growing in popularity as they can be designed to reflect a drug’s MoA, which is required by regulatory authorities to ensure efficacy and safety. Another area where functional assessment has gained traction is in relation to the complement system where drugs can interact with complement components and cause adverse effects.